01851nam a2200325 4500 7583 9291681229 7583 20030115d2002 y0pory50 ba eng Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs European Monitoring Centre for Drugs and Drug Addiction Luxembourg Office for Official Publications of the European Communities 2002 92 p. 21 cm Implemention of the joint action 4 Informação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: https://www.emcdda.org Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Europol-EMCDDS progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risk of GHB. Public health risk of GHB - epidemiological evidence. DROGAS ILÍCITAS 6631 SUBSTÂNCIAS PSICOTRÓPICAS 6333 COOPERAÇÃO INTERNACIONAL 581 SAÚDE PÚBLICA 1370 EUROPOL 103050 CONSELHO DA EUROPA 6334 EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA 5764 DRO321 0 DRO_321_000000000000000 2021-12-17 4435 10369 DGRSP DGRSP DGRSP4435526872 DRO321 2021-12-17 0 MO oferta